PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETS
Abstract
Authors
N.Y. Kirson A. White H.G. Birnbaum M. Schiller T. Waldman R. Ben-Joseph K. Summers